All news

Abbott sets October 21 earnings date, trades 17.6% below target

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

Abbott Laboratories is scheduled to release its third-quarter results on October 21, 2026. The stock was trading pre-market at EUR 91.62 on October 14, 2026. The company also announced a quarterly dividend of USD 0.63 with an ex-dividend date of October 15, 2026, and recently received an upgrade to a buy rating from Rothschild & Co Redburn.

Read original source

ABT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.